Complete Genomics Appoints Entrepreneur and Investor Lauren Selig to Board of Directors Complete Genomics, a U.S.-based company specializing in end-to-end DNA sequencing platforms, reagents, and software, has announced the appointment of entrepreneur, investor, and film producer Lauren Selig to its…
Stuart Therapeutics Appoints David Jakeman as Chief Financial Officer to Support Late-Stage Development and Commercialization Plans Stuart Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing first-in-class collagen-reparative therapeutics for ophthalmic diseases, has announced the appointment of David Jakeman as…
Nanochon Secures Panamá Health Ministry Approval to Begin First-in-Human Chondrograft™ Clinical Study Radiation Detection Company (RDC), a long-established provider of occupational radiation dosimetry services, has announced the launch of Radiant, a real-time electronic dosimetry solution designed to provide healthcare professionals…
FDA Approves LEROCHOL Autoinjector for Once-Monthly Self-Administration in Patients With High Cholesterol LIB Therapeutics, Inc. (LIB), a privately held biopharmaceutical company focused on helping high-risk patients achieve and maintain recommended cholesterol levels, announced that the U.S. Food and Drug Administration…
U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb’s ZENBEXUS™ in Combination Therapy for Multiple Myeloma at First Relapse Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has approved ZENBEXUS™ (iberdomide) in combination with daratumumab…
Clinilabs Expands Leadership Team With Laura Shannon as CEO as Founder Gary Zammit Moves to Executive Chairperson Clinilabs, a specialty contract research organization (CRO) focused on the development of central nervous system (CNS) drugs and medical devices, has announced an…
ILiAD Biotechnologies Strengthens Leadership Team With Veteran Vaccine Executives as BPZE1 Advances Toward Late-Stage Development ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical-stage biotechnology company focused on developing innovative approaches to prevent and treat diseases caused by Bordetella pertussis, has announced…
ImmunityBio Appoints Global Health Leader Dr. Jim Yong Kim as Vice Chairman to Strengthen International Partnerships and Expand Global Healthcare Access ImmunityBio, Inc., a commercial-stage biotechnology company focused on developing and delivering immunotherapy-based treatments, has announced the appointment of Dr.…
Diabetes and Metabolism Specialists Improves Patient Engagement and Chronic Care Management with eClinicalWorks Digital Solutions eClinicalWorks®, a leading ambulatory cloud electronic health record (EHR) provider, announced that Diabetes and Metabolism Specialists, a high-volume endocrinology practice, has achieved significant operational and…
Clinilabs Strengthens Executive Leadership with the Appointments of Dr. Bob Dagher as Chief Medical Officer and Dr. Waqar Ahmed Siddiqui as Principal Investigator Clinilabs LLC, a global full-service contract research organization (CRO) specializing in the development of therapies for central…
Synthekine Appoints Biotechnology Veteran Dr. Susan M. Molineaux as CEO to Lead Next Phase of Oncology Drug Development Synthekine, Inc., a clinical-stage biotechnology company focused on developing precision cytokine therapeutics for cancer and immune-mediated diseases, has announced the appointment of…
Mosaic Therapeutics Strengthens Leadership with Appointment of Dr. Allison Jeynes as Board Chair to Drive Clinical Growth Mosaic Therapeutics, a biotechnology company focused on developing innovative targeted combination therapies for hematological and solid cancers, has announced the appointment of Dr.…